Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BNTC
#2504
Benitec Biopharma Inc. Common Stock
10.900
0
-0.05%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.05%
Monthly Change
-12.03%
6 month change
-34.38%
Cambio anual
-34.38%
Cierres anteriores
10.905
0
Open
10.900
0
Bid
Ask
Low
10.900
0
High
10.900
0
Volumen
21
Markets
Acciones
Atención Sanitaria
BNTC
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
480.69 K
480.69 K
2.55 M
10.56 M
26.25 M
—
Valuation ratios
Enterprise value
—
—
—
25.78 M
209.43 M
1.09 B
Price to earnings ratio
—
—
—
-1.32
-11.14
-55.92
Price to sales ratio
—
—
—
—
507.36
—
Price to cash flow ratio
—
—
—
-1.52
-17.96
-73.48
Price to book ratio
—
—
—
0.62
4.35
7.36
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.65
3.05
4.38
0.42
0.38
0.33
Return on equity %
0.69
6.32
96.84
0.46
0.39
0.35
Return on invested capital %
4 482.53
3 514.9
3 266.88
3 003.67
6 764.5
—
Gross margin %
100
100
100
—
100
—
Operating margin %
23.04 K
24.46 K
25.44 K
—
5 001.8
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
23.53 K
24.94 K
26.08 K
—
4 540.96
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
15.05
1.9
0.94
10.49
54.67
184.12
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0.01
0.01
0
0.01
-0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
33.08
12.99
4.78
0.65
0.47
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
8.53
1.8
12.54
2.7
11.77
Net current asset value per share
—
10.03
2.69
12.73
2.72
11.83
Tangible book value per share
—
6
0.15
11.64
2.69
11.54
Working capital per share
—
4.76
-0.18
11.51
2.67
11.49
Book value per share
—
6
0.15
11.64
2.69
11.54
Noticias
Benitec BioPharma mantiene calificación tras datos de terapia génica
Calificación de Benitec BioPharma se mantiene tras datos de terapia génica
Benitec BioPharma stock rating maintained on gene therapy data
Benitec presentará resultados del estudio de terapia génica BB-301 en marzo
Benitec presentará resultados de terapia génica BB-301 en marzo
Benitec to present BB-301 gene therapy study results in March
Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade
Citizens reitera calificación de Mejor Rendimiento para la acción de Benitec BioPharma
Citizens mantiene calificación de Superar Mercado para acciones de Benitec BioPharma
Citizens reiterates Market Outperform rating on Benitec BioPharma stock
Benitec BioPharma mantiene calificación de Compra en TD Cowen tras sólidos datos de OPMD
Benitec BioPharma mantiene calificación de Compra en TD Cowen por sólidos datos de OPMD